In the original article, there was an erroring in the title, which was missing the word “Receptor”.
A correction has been made to the title as follows: Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
acquired resistance, breast cancer, endocrine resistance, endocrine therapy, estrogen receptor, de novo resistance
Citation
Belachew EB and Sewasew DT (2021) Corrigendum: Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer. Front. Endocrinol. 12:689705. doi: 10.3389/fendo.2021.689705
Received
01 April 2021
Accepted
14 April 2021
Published
11 May 2021
Volume
12 - 2021
Edited and reviewed by
Claire Perks, University of Bristol, United Kingdom
Updates
Copyright
© 2021 Belachew and Sewasew.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Esmael Besufikad Belachew, getbb2006@gmail.com
This article was submitted to Cancer Endocrinology, a section of the journal Frontiers in Endocrinology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.